ArticleScientific reports2025
HyperFusionNet combines vision transformer for early melanoma detection and precise lesion segmentation.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Transformer-Based Foundation Learning for Robust and Data-Efficient Skin Disease Imaging.Diagnostics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Early and accurate diagnosis of melanoma remains a major challenge due to the heterogeneous nature of skin lesions and the limitations of traditional diagnostic tools. In this study, we introduce HyperFusion-Net, a novel hybrid deep learning architecture that synergistically integrates a Multi-Path Vision Transformer (MPViT) and an attention U-Net to simultaneously perform melanoma classification and lesion segmentation in dermoscopic images. Unlike conventional CNN-based methods, HyperFusion-Net combines the general feature extraction capabilities of transducers with the spatial accuracy of the U-Net, which is enhanced by a mutual attention fusion block that facilitates the effective fusion of semantic and spatial features. The model was trained and evaluated using four public ISIC datasets containing over 60,000 dermoscopic images. Preprocessing techniques such as hair removal, clipping, and normalization were applied to improve robustness. Experimental results show that HyperFusion-Net consistently outperforms state-of-the-art models including U-Net, DeepLabV3 + , TransUNet, and Swin-UNet, achieving superior performance in classification (accuracy: 93.24%, AUC: 95.80%) and segmentation (Dice coefficient: 0.945 in ISIC 2024). Ablation studies confirm the effectiveness of the multi-path design and fusion strategy in enhancing diagnostic performance while maintaining computational efficiency. Furthermore, the model demonstrates strong generalizability across datasets with different lesion types and imaging conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.